Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

VA Drug Coverage Expansion Proposed; Fallback If Medicare Rx Fails?

Executive Summary

A proposal by Senate Veterans Affairs Committee Chairman Arlen Specter (R-Pa.) to offer all Medicare-eligible veterans access to VA drug prices is the latest possible senior drug coverage fallback bill to be introduced in Congress

You may also be interested in...



Medicare Rx May Have Little Effect On VA Health System, Department Says

The Medicare prescription drug benefit may have little effect on the Department of Veterans Affairs health care system, VA said

Medicare Rx May Have Little Effect On VA Health System, Department Says

The Medicare prescription drug benefit may have little effect on the Department of Veterans Affairs health care system, VA said

Procrit Medicare Charges Would Drop Almost $100 Mil. Using 85% Of AWP

Reimbursement for Johnson & Johnson's Procrit under Medicare Part B would drop about $100 mil. under a recent proposal to reduce Medicare Part B drug reimbursement by 10.5%

Latest Headlines
See All
UsernamePublicRestriction

Register

PS041913

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel